A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male Subjects
Clinical trial NCT02632526 · COMPLETED
Trial details
- NCT number
- NCT02632526
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-10
- Primary completion
- 2016-08-26
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.